Pesticide testing is not currently required in Colorado but, scientists at the lab predict that it will in mandated in the coming months.
The drug is already being studied in a Phase 3 Health Canada approved clinical trial for advanced cancer pain.
The six-month study will be led by Gold Coast Neurologist, Dr. Arman Sabet who has been involved in many international clinical trials specializing in neuromuscular disorders and stroke.
Deciphering the ways cannabis acts in the body to alter appetite could lead to new treatments for illness-induced anorexia common in cancer, HIV/AIDS, heart disease, and some metabolic disorders.
To date, the only cure for SCD is a bone marrow transplant, which is costly and out of reach for most patients.
Digipath is pleased to announce that Dr. Yunfeng Pan, PhD, has joined Digipath Labs as its Analytical Laboratory Director with oversight of analytical testing procedures.
Researchers at ebbu are using human clinical studies to track and record how different strains affect different patients to help users find the cannabis product they want and need.